TY - JOUR AU - Riley, J. L. PY - 2009 DA - 2009// TI - PD-1 signaling in primary T cells JO - Immunol Rev VL - 229 UR - https://doi.org/10.1111/j.1600-065X.2009.00767.x DO - 10.1111/j.1600-065X.2009.00767.x ID - Riley2009 ER - TY - JOUR AU - Blank, C. AU - Mackensen, A. PY - 2007 DA - 2007// TI - Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion JO - Cancer Immunol Immunother VL - 56 UR - https://doi.org/10.1007/s00262-006-0272-1 DO - 10.1007/s00262-006-0272-1 ID - Blank2007 ER - TY - JOUR AU - Dong, H. AU - Strome, S. E. AU - Salomao, D. R. AU - Tamura, H. AU - Hirano, F. AU - Flies, D. B. PY - 2002 DA - 2002// TI - Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion JO - Nat Med VL - 8 UR - https://doi.org/10.1038/nm730 DO - 10.1038/nm730 ID - Dong2002 ER - TY - JOUR AU - Dong, H. AU - Chen, L. PY - 2003 DA - 2003// TI - B7-H1 pathway and its role in the evasion of tumor immunity JO - J Mol Med VL - 81 UR - https://doi.org/10.1007/s00109-003-0430-2 DO - 10.1007/s00109-003-0430-2 ID - Dong2003 ER - TY - JOUR AU - Oguejiofor, K. AU - Galletta-Williams, H. AU - Dovedi, S. J. AU - Roberts, D. L. AU - Stern, P. L. AU - West, C. M. PY - 2017 DA - 2017// TI - Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.14796 DO - 10.18632/oncotarget.14796 ID - Oguejiofor2017 ER - TY - JOUR AU - Lu, C. AU - Redd, P. S. AU - Lee, J. R. AU - Savage, N. AU - Liu, K. PY - 2016 DA - 2016// TI - The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1247135 DO - 10.1080/2162402X.2016.1247135 ID - Lu2016 ER - TY - JOUR AU - Huang, Z. Y. AU - Xu, P. AU - Li, J. H. AU - Zeng, C. H. AU - Song, H. F. AU - Chen, H. PY - 2017 DA - 2017// TI - Clinical significance of dynamics of programmed death Ligand-1 expression on circulating CD14(+) monocytes and CD19(+) B cells with the progression of hepatitis B virus infection JO - Viral Immunol VL - 30 UR - https://doi.org/10.1089/vim.2016.0122 DO - 10.1089/vim.2016.0122 ID - Huang2017 ER - TY - JOUR AU - Zhang, Y. AU - Zhu, W. AU - Zhang, X. AU - Qu, Q. AU - Zhang, L. PY - 2017 DA - 2017// TI - Expression and clinical significance of programmed death-1 on lymphocytes and programmed death ligand-1 on monocytes in the peripheral blood of patients with cervical cancer JO - Oncol Lett VL - 14 ID - Zhang2017 ER - TY - JOUR AU - Dieterich, L. C. AU - Ikenberg, K. AU - Cetintas, T. AU - Kapaklikaya, K. AU - Hutmacher, C. AU - Detmar, M. PY - 2017 DA - 2017// TI - Tumor-associated lymphatic vessels upregulate PDL1 to inhibit T-cell activation JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.00066 DO - 10.3389/fimmu.2017.00066 ID - Dieterich2017 ER - TY - JOUR AU - He, H. AU - Qi, L. AU - Xiao, Y. AU - Hou, Y. PY - 2017 DA - 2017// TI - Tumor Associated Fibroblasts Promote PD-L1 Expression in Lung Cancer Cells JO - Zhongguo fei ai za zhi = Chinese journal of lung cancer VL - 20 ID - He2017 ER - TY - JOUR AU - Casadevall, D. AU - Clave, S. AU - Taus, A. AU - Hardy-Werbin, M. AU - Rocha, P. AU - Lorenzo, M. PY - 2017 DA - 2017// TI - Heterogeneity of tumor and immune cell PD-L1 expression and lymphocyte counts in surgical NSCLC samples JO - Clin Lung Cancer VL - 18 UR - https://doi.org/10.1016/j.cllc.2017.04.014 DO - 10.1016/j.cllc.2017.04.014 ID - Casadevall2017 ER - TY - JOUR AU - Tarhini, A. A. AU - Zahoor, H. AU - Yearley, J. H. AU - Gibson, C. AU - Rahman, Z. AU - Dubner, R. PY - 2015 DA - 2015// TI - Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma JO - J Transl Med VL - 13 UR - https://doi.org/10.1186/s12967-015-0678-7 DO - 10.1186/s12967-015-0678-7 ID - Tarhini2015 ER - TY - JOUR AU - Lee, L. H. AU - Cavalcanti, M. S. AU - Segal, N. H. AU - Hechtman, J. F. AU - Weiser, M. R. AU - Smith, J. J. PY - 2016 DA - 2016// TI - Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma JO - Mod Pathol VL - 29 UR - https://doi.org/10.1038/modpathol.2016.139 DO - 10.1038/modpathol.2016.139 ID - Lee2016 ER - TY - JOUR AU - Pinto, N. AU - Park, J. R. AU - Murphy, E. AU - Yearley, J. AU - McClanahan, T. AU - Annamalai, L. PY - 2017 DA - 2017// TI - Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors JO - Pediatr Blood Cancer VL - 64 UR - https://doi.org/10.1002/pbc.26613 DO - 10.1002/pbc.26613 ID - Pinto2017 ER - TY - JOUR AU - Thompson, E. D. AU - Zahurak, M. AU - Murphy, A. AU - Cornish, T. AU - Cuka, N. AU - Abdelfatah, E. PY - 2017 DA - 2017// TI - Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma JO - Gut VL - 66 UR - https://doi.org/10.1136/gutjnl-2015-310839 DO - 10.1136/gutjnl-2015-310839 ID - Thompson2017 ER - TY - JOUR AU - Scognamiglio, T. AU - Chen, Y. T. PY - 2017 DA - 2017// TI - Beyond the percentages of PD-L1-positive tumor cells: induced versus constitutive PD-L1 expression in primary and metastatic head and neck squamous cell carcinoma JO - Head Neck Pathol VL - 12 UR - https://doi.org/10.1007/s12105-017-0857-3 DO - 10.1007/s12105-017-0857-3 ID - Scognamiglio2017 ER - TY - JOUR AU - Taube, J. M. AU - Anders, R. A. AU - Young, G. D. AU - Xu, H. AU - Sharma, R. AU - McMiller, T. L. PY - 2012 DA - 2012// TI - Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape JO - Sci Transl Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3003689 DO - 10.1126/scitranslmed.3003689 ID - Taube2012 ER - TY - JOUR AU - Liang, M. AU - Yang, H. AU - Fu, J. PY - 2009 DA - 2009// TI - Nimesulide inhibits IFN-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells by COX-2 and PGE2 independent mechanisms JO - Cancer Lett VL - 276 UR - https://doi.org/10.1016/j.canlet.2008.10.028 DO - 10.1016/j.canlet.2008.10.028 ID - Liang2009 ER - TY - JOUR AU - Azuma, K. AU - Ota, K. AU - Kawahara, A. AU - Hattori, S. AU - Iwama, E. AU - Harada, T. PY - 2014 DA - 2014// TI - Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu242 DO - 10.1093/annonc/mdu242 ID - Azuma2014 ER - TY - JOUR AU - Parsa, A. T. AU - Waldron, J. S. AU - Panner, A. AU - Crane, C. A. AU - Parney, I. F. AU - Barry, J. J. PY - 2007 DA - 2007// TI - Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1517 DO - 10.1038/nm1517 ID - Parsa2007 ER - TY - JOUR AU - Melcher, A. AU - Parato, K. AU - Rooney, C. M. AU - Bell, J. C. PY - 2011 DA - 2011// TI - Thunder and lightning: immunotherapy and oncolytic viruses collide JO - Mol Ther VL - 19 UR - https://doi.org/10.1038/mt.2011.65 DO - 10.1038/mt.2011.65 ID - Melcher2011 ER - TY - JOUR AU - Gruijl, T. D. AU - Janssen, A. B. AU - Beusechem, V. W. PY - 2015 DA - 2015// TI - Arming oncolytic viruses to leverage antitumor immunity JO - Expert Opin Biol Ther VL - 15 UR - https://doi.org/10.1517/14712598.2015.1044433 DO - 10.1517/14712598.2015.1044433 ID - Gruijl2015 ER - TY - JOUR AU - Bartee, M. Y. AU - Dunlap, K. M. AU - Bartee, E. PY - 2017 DA - 2017// TI - Tumor-localized secretion of soluble PD1 enhances oncolytic Virotherapy JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-1638 DO - 10.1158/0008-5472.CAN-16-1638 ID - Bartee2017 ER - TY - JOUR AU - Madore, J. AU - Vilain, R. E. AU - Menzies, A. M. AU - Kakavand, H. AU - Wilmott, J. S. AU - Hyman, J. PY - 2015 DA - 2015// TI - PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials JO - Pigment Cell Melanoma Res VL - 28 UR - https://doi.org/10.1111/pcmr.12340 DO - 10.1111/pcmr.12340 ID - Madore2015 ER - TY - JOUR AU - Robert, C. PY - 2017 DA - 2017// TI - Checkpoint blockade plus oncolytic virus: a hot therapeutic Cancer strategy JO - Trends Mol Med VL - 23 UR - https://doi.org/10.1016/j.molmed.2017.09.008 DO - 10.1016/j.molmed.2017.09.008 ID - Robert2017 ER - TY - JOUR AU - Kim, H. R. AU - Ha, S. J. AU - Hong, M. H. AU - Heo, S. J. AU - Koh, Y. W. AU - Choi, E. C. PY - 2016 DA - 2016// TI - PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep36956 DO - 10.1038/srep36956 ID - Kim2016 ER - TY - JOUR AU - Juneja, V. R. AU - McGuire, K. A. AU - Manguso, R. T. AU - LaFleur, M. W. AU - Collins, N. AU - Haining, W. N. PY - 2017 DA - 2017// TI - PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity JO - J Exp Med VL - 214 UR - https://doi.org/10.1084/jem.20160801 DO - 10.1084/jem.20160801 ID - Juneja2017 ER - TY - JOUR AU - Liu, Z. AU - Ravindranathan, R. AU - Kalinski, P. AU - Guo, Z. S. AU - Bartlett, D. L. PY - 2017 DA - 2017// TI - Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms14754 DO - 10.1038/ncomms14754 ID - Liu2017 ER - TY - JOUR AU - Samson, A. AU - Scott, K. J. AU - Taggart, D. AU - West, E. J. AU - Wilson, E. AU - Nuovo, G. J. PY - 2018 DA - 2018// TI - Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade JO - Sci Transl Med VL - 10 UR - https://doi.org/10.1126/scitranslmed.aam7577 DO - 10.1126/scitranslmed.aam7577 ID - Samson2018 ER - TY - JOUR AU - Zamarin, D. AU - Ricca, J. M. AU - Sadekova, S. AU - Oseledchyk, A. AU - Yu, Y. AU - Blumenschein, W. M. PY - 2018 DA - 2018// TI - PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI125039 DO - 10.1172/JCI125039 ID - Zamarin2018 ER - TY - JOUR AU - Gato-Canas, M. AU - Zuazo, M. AU - Arasanz, H. AU - Ibanez-Vea, M. AU - Lorenzo, L. AU - Fernandez-Hinojal, G. PY - 2017 DA - 2017// TI - PDL1 signals through conserved sequence motifs to overcome interferon-mediated cytotoxicity JO - Cell Rep VL - 20 UR - https://doi.org/10.1016/j.celrep.2017.07.075 DO - 10.1016/j.celrep.2017.07.075 ID - Gato-Canas2017 ER - TY - JOUR AU - Clark, C. A. AU - Gupta, H. B. AU - Sareddy, G. AU - Pandeswara, S. AU - Lao, S. AU - Yuan, B. PY - 2016 DA - 2016// TI - Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis, and autophagy in ovarian Cancer and melanoma JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-16-0258 DO - 10.1158/0008-5472.CAN-16-0258 ID - Clark2016 ER -